Literature DB >> 1470229

Effects of the triazole derivative loreclezole (R72063) on stimulus induced ionic and field potential responses and on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex-hippocampal slices.

C L Zhang1, U Heinemann.   

Abstract

Effects of loreclezole (R72063), a triazole derivative with anticonvulsant properties, were studied on field potentials in rat hippocampal slices and on different patterns of low Mg(2+)-induced epileptiform activity in combined entorhinal cortex-hippocampal slices. Lowering extracellular Mg2+ induced recurrent (10-60/min), short (40-80 ms) discharges in hippocampal areas CA1 and CA3. In the entorhinal cortex (EC) up to 90 s long ictaform events associated with large negative field potential and changes in the neuronal microenvironment were generated. These seizure like events changed their characteristics after one to two hours to recurrent discharges of 0.8 to 10 s. 20 microM loreclezole blocked the seizure like events in the entorhinal cortex completely 30-80 min after onset of application. The recurrent short discharges in the hippocampus were reliably blocked by 40 muM loreclezole 60-90 min after bath application with incomplete recovery after washout of several hours. The recurrent discharges in the entorhinal cortex were reliably blocked by 80 microM loreclezole applied for 80-100 min. Decreases in [Ca2+]o and associated slow field potentials evoked by repetitive stimulation of the stratum radiatum were depressed in a dose dependent manner, while similar changes induced by alvear stimulation remained almost unaffected. A paired pulse stimulus paradigm used to test for effect of loreclezole on synaptically evoked transient field potentials in normal medium revealed interference with mechanisms involved in frequency potentiation. While responses to alvear stimulation were largely unaffected, the response to a paired pulse stimulus to stratum radiatum was depressed over the whole range of tested stimulus intervals (15 to 150 ms). The findings suggest that loreclezole has effects on different patterns of epileptiform activity induced by extracellular low Mg2+ possibly by interfering with processes leading to frequency potentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470229     DOI: 10.1007/bf00169016

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

Review 1.  In vitro epileptiform activity: role of excitatory amino acids.

Authors:  U Heinemann; J Arens; J P Dreier; J Stabel; C L Zhang
Journal:  Epilepsy Res       Date:  1991-10       Impact factor: 3.045

Review 2.  Calcium, excitotoxins, and neuronal death in the brain.

Authors:  B K Siesjö; F Bengtsson; W Grampp; S Theander
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Calcium dependence of presynaptic calcium current and post-synaptic response at the squid giant synapse.

Authors:  G J Augustine; M P Charlton
Journal:  J Physiol       Date:  1986-12       Impact factor: 5.182

4.  Presynaptic calcium diffusion and the time courses of transmitter release and synaptic facilitation at the squid giant synapse.

Authors:  R S Zucker; N Stockbridge
Journal:  J Neurosci       Date:  1983-06       Impact factor: 6.167

5.  Seizure activity in vitro: a dual focus model.

Authors:  W A Wilson; H S Swartzwelder; W W Anderson; D V Lewis
Journal:  Epilepsy Res       Date:  1988 Sep-Oct       Impact factor: 3.045

Review 6.  The role of calcium in cell death.

Authors:  J L Farber
Journal:  Life Sci       Date:  1981-09-28       Impact factor: 5.037

7.  Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients.

Authors:  T Rentmeester; J Hulsman
Journal:  Epilepsy Res       Date:  1991-03       Impact factor: 3.045

8.  Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices.

Authors:  I Mody; J D Lambert; U Heinemann
Journal:  J Neurophysiol       Date:  1987-03       Impact factor: 2.714

9.  A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures.

Authors:  T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J Meijer; F de Beukelaar
Journal:  Epilepsy Res       Date:  1991 May-Jun       Impact factor: 3.045

10.  Pharmacological characterization of opioid effects in the rat hippocampal slice.

Authors:  R J Valentino; R Dingledine
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

View more
  1 in total

Review 1.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.